SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Medical System Wants To Be Housing Provider
HEALTH: Plans Aim to Cut Congestion, Fund InfrastructureLong a provider of housing for university students, UC San Diego is now pushing for dwellings for employees of its medical system.FDA Fast-Track Designation for Cidara Therapeutics
San Diego-based Cidara Therapeutics gained fast-track status from the U.S. Food and Drug Administration for its lead drug candidate aimed at preventing invasive fungal infections, the company announced Sept. 25.
Equillium Prepares $86M IPO
La Jolla-based Equillium intends to raise $86 million through an initial public offering, according to recently filed U.S. Securities and Exchange Commission paperwork.
La Jolla Vein Care Adds Space
La Jolla Vein Care – which treats vein disease and disorders – recently doubled its clinic space.
ICYMI: Ex-Illumina Leaders Form Own Cos. To Pursue Genomics Work
Kevin Gunderson was employee No. 7 of 6,000 at Illumina. He led the company’s advanced research group for almost 18 years, helping create its first $1 billion product line.
Epic Aims to ‘Revolutionize Cancer Care’
MEDICINE: Extending Lives, Cutting Waste Are Part of Goals
Epic Sciences’ pitch: greater certainty. The company’s portfolio of tests guide cancer doctors deciding on a treatment path, including a test on the market for advanced prostate cancer.
Ionis’ Huntington’s Drug Heads to Final-Stage Trial
Medications can help manage symptoms of Huntington’s disease. But invariably sufferers are robbed of mental and physical abilities.
Life Sciences Reporter's Notebook: Heron Hoping for A Political Solution
The U.S. Senate on Sept. 17 passed bipartisan legislation to combat the opioid epidemic. For at least one San Diego biotech, a notable measure was missing.
Acadia’s Stock Surges on FDA Reaffirming Drug
The U.S. Food and Drug Administration didn’t find new safety concerns after reexamining Acadia Pharmaceutical’s drug to treat hallucinations and delusions caused by Parkinson’s disease.
Alliance Healthcare Foundation Awards $2M to Local Organizations
San Diego-based Alliance Healthcare Foundation established has a new $2 million fund with the San Diego Foundation. That money will be split between the Multicultural Health Foundation and Somali Family Services.
Life Sciences Reporter's Notebook: Clearity Marks 10 Years in Ovarian Cancer Fight
Laura Shawver — perhaps best known as the CEO of Synthorx — launched the Clearity Foundation after her own experience with ovarian cancer.
Samumed Inks Licensing Deal Worth Up To $350M
United Therapeutics Corporation gained North American licensing rights to a lung disease drug from San Diego’s Samumed in a deal announced Sept. 17.
Illumina’s Progress Creates Encouraging Ecosystem for Others
In 2000, the cost to sequence a genome stood at $100 million.
ViaCyte Set to Receive $15M in Diabetes Collaboration
ViaCyte, a San Diego stem cell therapy biotech, has teamed up with a Massachusetts gene-editing company to take on diseases like diabetes.
Sherpa Clinical Packaging Acquired
San Diego-based Sherpa Clinical Packaging has been acquired by PCI Pharma Services under a deal announced Sept. 11 in which terms were not disclosed.
Prev Next